Table 6.
Rifaximin (n=67) | Herbal (n=37) | P value | |
---|---|---|---|
Age (yrs) | 47.55 ± 15.73 | 41.6 ± 16.3 | .07 |
Percent female | 48 (71%) | 29 (78%) | .45 |
Risk Factors for SIBO | 9 (13%) | 7 (19%) | .46 |
Diabetes mellitus | 4 (6%) | 0 (0%) | .12 |
Gastroparesis | 2 (3%) | 1 (3%) | .93 |
Narcotic | 1 (1%) | 3 (8%) | .09 |
CTD | 2 (3%) | 4 (11%) | .1 |
Any risk factor | 9 (13%) | 7 (19%) | .46 |
IBS | 53 (79%) | 25 (68%) | .19 |
Distribution of IBS by Subtypes | .08 | ||
None | 14 (21%) | 12 (32%) | |
Diarrhea predominant | 22 (32%) | 6 (16%) | |
Constipation predominant | 16 (24%) | 12 (32%) | |
Mixed | 14 (21%) | 4 (11%) | |
Unclassified IBS | 1 (1%) | 3 (8%) | |
Negative LBT after Rx | 23 (34%) | 17 (46%) | .24 |